ePoster
Switch To Module
Conference Calendar
ePoster
AUTHORS
GENERAL SEARCH
GENERAL SEARCH
Session Title
Title
Poster Number
Role Authors
Presenter
Abstract
Filter By
Session Name
Select All
Deselect All
E-POSTER DISCUSSION SESSION 01: ANTIMICROBIAL
9
E-POSTER DISCUSSION SESSION 02: LABORATORY & ANTIMICROBIAL RESISTANCE
8
E-POSTER DISCUSSION SESSION 03: VACCINES 1
7
E-POSTER DISCUSSION SESSION 04: COVID EPIDEMIOLOGY
8
E-POSTER DISCUSSION SESSION 05: COVID CLINICAL
8
E-POSTER DISCUSSION SESSION 06: COVID DIAGNOSTICS
7
E-POSTER DISCUSSION SESSION 07: CNS DISEASE
7
E-POSTER DISCUSSION SESSION 08: PNEUMOCOCCUS
7
E-POSTER DISCUSSION SESSION 09: OTHER PERSPECTIVES
8
E-POSTER DISCUSSION SESSION 10: IMMUNOCOMPROMISED HOSTS
3
E-POSTER DISCUSSION SESSION 11: GENERAL PID
8
E-POSTER DISCUSSION SESSION 12: CONGENITAL INFECTIONS
7
E-POSTER DISCUSSION SESSION 13: VIRAL RESPIRATORY INFECTIONS
7
E-POSTER DISCUSSION SESSION 14: VACCINES 2
9
MEET THE EXPERT E-POSTERS
15
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - BACTERIAL PNEUMONIA
5
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - CLINICAL MANIFESTATIONS
32
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - CNS INFECTIONS
6
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - CONGENITAL AND PERINATAL INFECTIONS
7
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - COVID-19 CLINICAL AND TREATMENT
3
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - CYTOMEGALOVIRUS
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - DIAGNOSTICS (SCREENING AND TESTING)
8
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - DIGITAL TOOLS AND MACHINE LEARNING FOR PEDIATRIC INFECTIOUS DISEASES
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - ENT INFECTIONS
4
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - EPIDEMIOLOGY AND RISK FACTORS
23
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - GASTROINTESTINAL INFECTIONS
6
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - HIV/AIDS
8
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - HOST RESPONSE DIAGNOSTICS AND IMAGING
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
8
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - INFECTIONS IN PEDIATRIC TRANSPLANT MEDICINE
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - MANAGING “TRIVIAL” INFECTIONS (YOUNG ESPID)
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - MICROBIOLOGY
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - MODELLING STUDIES
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - MULTIDRUG-RESISTANT BACTERIA AND THE SPREAD OF ANTIMICROBIAL RESISTANCE
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - NEAR-PATIENT, RAPID TESTING
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - NEONATAL SEPSIS
9
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - NEW DEVELOPMENTS IN ANTIBIOTIC TREATMENT
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - NOVEL ANTIMICROBIAL TREATMENTS
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - NOVEL DIAGNOSTICS
6
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - OTHER
30
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - PEDIATRIC COIVD-19 CLINICAL PRESENTATION AND TREATMENT
5
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - PHARMACOLOGY
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - POPULATION STUDIES AND SURVEILLANCE
55
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - PREVENTION OF SARS-COV-2 TRANSMISSION
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - PREVENTION OF TRANSMISSION
4
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - REFUGEES AND MIGRANTS
3
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - RESISTANCE
12
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - SKIN INFECTIONS
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - SYSTEMIC AND MULTI-ORGAN INFECTIONS
10
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - TB AND HIV
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - THE SPREAD OF ANTIMICROBIAL RESISTANCE
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - TREATMENT
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - TROPICAL/PARASITE INFECTIONS & TRAVEL MEDICINE
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - TUBERCULOSIS AND OTHER MYCOBACTERIAL INFECTIONS
8
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - UROGENITAL INFECTIONS
3
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - VACCINE DEVELOPMENT (PHASE 1-2) – BACTERIAL AND ALL NON-VIRAL
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - VACCINE EFFICACY (PHASE 3) AND EFFECTIVENESS – BACTERIAL AND ALL NON-VIRAL
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - VACCINE EFFICACY (PHASE 3) AND EFFECTIVENESS – VIRAL
2
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - VACCINE HESITANCY
8
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - VACCINE SAFETY (POST LICENSURE)
8
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - VACCINES
4
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - VACCINES IN THE SPOTLIGHT OF PANDEMICS
1
TYPE 1: CLINICAL AUDIT, PROSPECTIVE SURVEY OR RETROPERSPECTIVE STUDY - VIRAL RESPIRATORY INFECTIONS
21
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - CLINICAL MANIFESTATIONS
1
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - CNS INFECTIONS
1
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - CYTOMEGALOVIRUS
1
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - DIGITAL TOOLS AND MACHINE LEARNING FOR PEDIATRIC INFECTIOUS DISEASES
1
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
1
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - NOVEL ANTIMICROBIAL TREATMENTS
2
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - OTHER
2
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - POPULATION STUDIES AND SURVEILLANCE
4
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - THE SPREAD OF ANTIMICROBIAL RESISTANCE
1
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - TUBERCULOSIS AND OTHER MYCOBACTERIAL INFECTIONS
1
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - VACCINE DEVELOPMENT (PHASE 1-2) – BACTERIAL AND ALL NON-VIRAL
1
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - VACCINE EFFICACY (PHASE 3) AND EFFECTIVENESS – BACTERIAL AND ALL NON-VIRAL
3
TYPE 2: LITERATURE REVIEW OR GUIDELINE REVIEW - VACCINE SAFETY (POST LICENSURE)
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - ANTIBIOTIC TREATMENT REVISITED
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - BACTERIAL PNEUMONIA
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - CLINICAL MANIFESTATIONS
9
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - CNS INFECTIONS
3
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - CONGENITAL AND PERINATAL INFECTIONS
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - COVID-19 CLINICAL AND TREATMENT
3
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - CYTOMEGALOVIRUS
3
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - DIAGNOSTICS (SCREENING AND TESTING)
5
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - EPIDEMIOLOGY AND RISK FACTORS
5
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - GASTROINTESTINAL INFECTIONS
3
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - HIV/AIDS
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - HOST-PATHOGEN INTERACTION
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - INFECTIONS IN PEDIATRIC TRANSPLANT MEDICINE
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - MICROBIOLOGY
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - NEONATAL SEPSIS
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - NOVEL DIAGNOSTICS
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - OTHER
9
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - PHARMACOLOGY
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - POPULATION STUDIES AND SURVEILLANCE
6
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - RESISTANCE
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - SYSTEMIC AND MULTI-ORGAN INFECTIONS
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - TB AND HIV
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - TROPICAL/PARASITE INFECTIONS & TRAVEL MEDICINE
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - TUBERCULOSIS AND OTHER MYCOBACTERIAL INFECTIONS
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - VACCINE DEVELOPMENT (PHASE 1-2) – VIRAL
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - VACCINE EFFICACY (PHASE 3) AND EFFECTIVENESS – BACTERIAL AND ALL NON-VIRAL
4
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - VACCINE HESITANCY
3
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - VACCINES
1
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - VIRAL RESPIRATORY INFECTIONS
2
TYPE 3: CLINICAL TRIAL/STUDY OR BASIC SCIENCE STUDY - ZOONOSIS, VECTOR-BORNE AND EMERGING INFECTIONS
2
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - CNS INFECTIONS
1
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - CONGENITAL AND PERINATAL INFECTIONS
3
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - GASTROINTESTINAL INFECTIONS
1
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - NEONATAL SEPSIS
1
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - OTHER
2
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - POPULATION STUDIES AND SURVEILLANCE
5
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - PREVENTION OF TRANSMISSION
1
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - VACCINE EFFICACY (PHASE 3) AND EFFECTIVENESS – BACTERIAL AND ALL NON-VIRAL
1
TYPE 4: FORMAL SYSTEMATIC REVIEW OR META-ANALYSIS - VIRAL RESPIRATORY INFECTIONS
1
TYPE 5: CASE REPORT OR CASE SERIES - BACTERIAL PNEUMONIA
3
TYPE 5: CASE REPORT OR CASE SERIES - BONE AND JOINT INFECTIONS
1
TYPE 5: CASE REPORT OR CASE SERIES - CLINICAL MANIFESTATIONS
35
TYPE 5: CASE REPORT OR CASE SERIES - CNS INFECTIONS
9
TYPE 5: CASE REPORT OR CASE SERIES - CONGENITAL AND PERINATAL INFECTIONS
9
TYPE 5: CASE REPORT OR CASE SERIES - CONGENITAL INFECTIONS
1
TYPE 5: CASE REPORT OR CASE SERIES - DIAGNOSTICS (SCREENING AND TESTING)
2
TYPE 5: CASE REPORT OR CASE SERIES - ENT INFECTIONS
1
TYPE 5: CASE REPORT OR CASE SERIES - EPIDEMIOLOGY AND RISK FACTORS
5
TYPE 5: CASE REPORT OR CASE SERIES - FEVER OF UNKNOWN ORIGIN
2
TYPE 5: CASE REPORT OR CASE SERIES - GASTROINTESTINAL INFECTIONS
10
TYPE 5: CASE REPORT OR CASE SERIES - HIV/AIDS
1
TYPE 5: CASE REPORT OR CASE SERIES - HOST-PATHOGEN INTERACTION
4
TYPE 5: CASE REPORT OR CASE SERIES - INFECTION AND IMMUNE COMPROMISED HOST
2
TYPE 5: CASE REPORT OR CASE SERIES - INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
10
TYPE 5: CASE REPORT OR CASE SERIES - MENINGITIS/ENCEPHALITIS
2
TYPE 5: CASE REPORT OR CASE SERIES - MODELLING STUDIES
1
TYPE 5: CASE REPORT OR CASE SERIES - MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C)
5
TYPE 5: CASE REPORT OR CASE SERIES - MYCOBACTERIA
3
TYPE 5: CASE REPORT OR CASE SERIES - NEONATAL SEPSIS
4
TYPE 5: CASE REPORT OR CASE SERIES - NOVEL ANTIMICROBIAL TREATMENTS
3
TYPE 5: CASE REPORT OR CASE SERIES - NOVEL DIAGNOSTICS
5
TYPE 5: CASE REPORT OR CASE SERIES - OTHER
25
TYPE 5: CASE REPORT OR CASE SERIES - PHARMACOLOGY
2
TYPE 5: CASE REPORT OR CASE SERIES - PIMS-TS / MIS-C
1
TYPE 5: CASE REPORT OR CASE SERIES - POPULATION STUDIES AND SURVEILLANCE
4
TYPE 5: CASE REPORT OR CASE SERIES - REFUGEES AND MIGRANTS
3
TYPE 5: CASE REPORT OR CASE SERIES - RESISTANCE
2
TYPE 5: CASE REPORT OR CASE SERIES - SEVERE/SYSTEMIC FUNGAL INFECTIONS
3
TYPE 5: CASE REPORT OR CASE SERIES - SKIN INFECTIONS
2
TYPE 5: CASE REPORT OR CASE SERIES - SYSTEMIC AND MULTI-ORGAN INFECTIONS
14
TYPE 5: CASE REPORT OR CASE SERIES - TREATMENT
1
TYPE 5: CASE REPORT OR CASE SERIES - TROPICAL INFECTIOUS DISEASES
4
TYPE 5: CASE REPORT OR CASE SERIES - TROPICAL/PARASITE INFECTIONS & TRAVEL MEDICINE
1
TYPE 5: CASE REPORT OR CASE SERIES - TUBERCULOSIS AND OTHER MYCOBACTERIAL INFECTIONS
17
TYPE 5: CASE REPORT OR CASE SERIES - UROGENITAL INFECTIONS
3
TYPE 5: CASE REPORT OR CASE SERIES - VACCINE SAFETY (POST LICENSURE)
1
TYPE 5: CASE REPORT OR CASE SERIES - VIRAL RESPIRATORY INFECTIONS
4
TYPE 5: CASE REPORT OR CASE SERIES - ZOONOSIS, VECTOR-BORNE AND EMERGING INFECTIONS
5
Cancel
Clear
Search
SEARCH BY POSTER TOPIC
e-Poster
Posters Author Search
Welcome to the ESPID 2021 E-Poster Gallery
The Meeting will officially run on CEST (GMT + 2 / UTC + 2)
Please add your email also in the body of the message in order to get a reply
